Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial
CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, May 8, 2026 Harbour BioMed announced that the U.S. Food and Drug...
FDA IND Clearance
Advertisement
BRC Therapeutics Secures FDA IND Clearance for BRC-002 Therapy
MONTEREY, California, USA, April 28, 2026 BRC Therapeutics has announced that the U.S. Food and Drug Administration has cleared...
CU Anschutz Secures FDA IND for CAR T-Cell Therapy
AURORA, Colo., April 2, 2026 The University of Colorado Anschutz Medical Campus Gates Institute announced it has received U.S....
Siren Biotech FDA IND Clearance for Glioma Trial
SAN FRANCISCO, CA, March 23, 2026 Siren Biotechnology has announced that the U.S. Food and Drug Administration (FDA) has...
FDA Clears First Nerve-Specific Imaging Agent for Surgery
PORTLAND, Ore., Jan. 31, 2026 — Trace Biosciences announced that the U.S. Food and Drug Administration (FDA) has granted...
Advertisements
FDA Clears Scancell IND for Phase 3 iSCIB1+ Melanoma Trial
Cambridge, United Kingdom, January 26, 2026 — Scancell Holdings plc announced on January 26, 2026, that the U.S. Food...
FDA Clears MRM Health’s Phase 2b Microbiome Trial in UC
GHENT, Belgium | January 9, 2026 — MRM Health announced that the U.S. Food and Drug Administration (FDA) has...
GenEditBio Wins FDA IND Clearance for GEB-101 Therapy
HONG KONG | January 5, 2026 — GenEditBio has received U.S. FDA clearance of its Investigational New Drug (IND)...
FDA Clears Ascletis ASC30 Phase II Diabetes Study
HONG KONG, Jan. 5, 2026 — Ascletis Pharma Inc. announced that it has received Investigational New Drug (IND) clearance...
FDA Clears Allogeneic CAR-T MT027 for Phase II Glioblastoma
December 21, 2025 | Beijing, China — T-MAXIMUM Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
